<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>AI for Clinical Candidate Selection | ChemBio AI Insights</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Space+Grotesk:wght@400;500;600;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="../assets/css/style.css" />
</head>
<body>
  <main class="article-layout">
    <div class="eyebrow">ChemBio AI Insights</div>
    <div class="article-header">
      <h1>AI for Clinical Candidate Selection</h1>
      <p class="article-meta"><a href="../category/pharma.html">Pharma</a> · Nov 24, 2025</p>
    </div>
    <article class="article-content">
      <p>Discovery teams are using AI to narrow the list of viable clinical candidates by uniting assay evidence, predicted ADME profiles, and safety signals. The goal: fewer surprises before first-in-human studies.</p>

      <h2>What teams are doing</h2>
      <ul>
        <li>LLMs summarize dossiers across tox, DMPK, and manufacturability so leads can be compared on a like-for-like basis.</li>
        <li>Predictive models estimate exposure and clearance for different dosing schemes to prioritize tolerable ranges.</li>
        <li>Simulation helps explore combination therapies and sequence effects before expensive in vivo work.</li>
      </ul>

      <h2>Keeping rigor high</h2>
      <p>Each model recommendation is paired with documented assumptions and validation runs. Scientists keep the loop tight with orthogonal assays and clear decision logs so candidates advance with fewer unknowns.</p>
    </article>
    <a class="back-link" href="../index.html" aria-label="Back to home">
      ← Back to home
    </a>
  </main>
  <footer>
    <p>© <span id="year"></span> ChemBio AI Insights.</p>
  </footer>
  <script src="../assets/js/main.js"></script>
</body>
</html>
